Zq. Cheng et al., GLUCURONIDATION OF CATECHOL ESTROGENS BY EXPRESSED HUMAN UDP-GLUCURONOSYLTRANSFERASES (UGTS) 1A1, 1A3, AND 2B7, TOXICOLOGICAL SCIENCES, 45(1), 1998, pp. 52-57
Catechol estrogens are major estrogen metabolites in mammals and are t
he most potent naturally occurring inhibitors of catecholamine metabol
ism. These estrogen compounds have been implicated in carcinogenic act
ivity and the 412-hydroxyestradiol concentration has been shown to be
elevated in neoplastic human mammary tissue compared to normal human b
reast tissue. Three human liver UDP-glucuronosyltransferases, UGT2B7,
UGT1A1, and UGT1A3, have been shown to catalyze the glucuronidation of
catechol estrogens and lead to their enhanced elimination via urine o
r bile. The present study was designed to study the kinetic interactio
n of expressed human UGT2B7(Y) or (H), UCT1A1, and UGT1A3 toward 2- an
d 4-hydroxycatechol estrogens. cDNAs encoding UGT2B7(Y) or (H), UGT1A1
, and UGT1A3 were expressed in HK293 cells, and cell homogenates or me
mbrane preparations were used to determine their glucuronidation abili
ty. UGT2B7(Y) reacted with higher efficiency toward 4-hydroxyestrogeni
c catechols, whereas UGT1A1 and UGT1A3 showed higher activities toward
2-hydroxyestrogens. UGT2B7(H) catalyzed estrogen catechol glucuronida
tion with efficiencies similar to UGT2B7(Y). Flunitrazepam (FNZ), a co
mpetitive inhibitor of morphine glucuronidation in hepatic microsomes,
competitively inhibited catechol estrogen glucuronidation catalyzed b
y UGT2B7(Y), UGT1A1, and UGT1A3. Buprenorphine, an opioid substrate th
at reacts at high efficiency with each of these UGTs, was also studied
. FNZ competitively inhibited buprenorphine glucuronidation with UGT1A
1 and UGT2B7 but had no inhibitory activity toward UGT1A3. This sugges
ts that buprenorphine and 2-hydroxycatechol estrogens react with separ
ate active sites of UGT1A3. A catecholamine, norepinephrine, did not i
nhibit UGT2B7(Y)-, UGT1A1-, and UGT1A3-catalyzed glucuronidation of ca
techol estrogens. These results also suggest that drug-endobiotic inte
ractions are possible in humans and may have implication in carcinogen
esis. (C) 1998 Society of Toxicology.